Brief: MG Med to buy 17.1 pct stake in Oxford Cancer Biomarkers for 3.40 bln won

Dx & Vx

08/05/2017 04:49

May 8 (Reuters) - MG Med Inc  180400.KQ  : 
     
    * Says it plans to buy 1,846 shares of Oxford Cancer 
Biomarkers Limited, a Scotland pharma firm, for 3.40 billion won 
    * Says it will hold 17.1 percent stake(1,846 shares) in 
target company after transaction  
     
     
    Source text in Korean: https://goo.gl/psTn6B 
    Further company coverage:  180400.KQ  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))